P-Rex1 deficiency was associated with impaired migration, invasion, and metastasis in mouse models of melanoma and prostate cancer; however, there was no significant reduction in proliferation or primary tumor burden (13, 17, 41). Here, OCA2 is linked to prostate carcinoma.